Nvidia has announced a strategic partnership with American biopharmaceutical firm Pfizer and various Singaporean organizations to support global healthcare startups expanding in Southeast Asia.

The newly launched Ignition AI Accelerator program aims to accelerate the development of innovative pharmaceuticals while fostering local industry growth.

The program will use AI tools to shorten drug development timelines, analyze extensive datasets, and offer faster insights, which could benefit emerging healthcare companies.

As part of this initiative, the program will pursue collaboration and integration among key stakeholders, including government bodies, universities, and business accelerators.